Disease
Atopic Dermatitis
Chronic, relapsing inflammatory skin disease driven by type 2/Th2 immune dysregulation and epidermal barrier dysfunction, presenting as pruritic, eczematous lesions; the most common chronic inflammatory skin disease in both adults and children.
Total attributable cost
$207.8B
$10,474/patient
Drug spend
$23.2B
$1,168/patient
11% of total cost is drugs
All severities, self-reported diagnosis (2024 NHIS) · US